Phase 2a Study of Baxdrostat in Primary Aldosteronism

By afschroeder • July 15, 2025

Turcu AF, Freeman MW, Bancos I, Ben-Shlomo A, Hamidi O, Hamrahian AH, Huang W, Kirschner LS, Sam R, Mallappa A, Tuyishimire B, Lihn AS, Perl S, Brown MJ; SPARK Investigator Group. Phase 2a Study of Baxdrostat in Primary Aldosteronism. N Engl J Med. 2025 Jul 13. doi: 10.1056/NEJMc2508629. Epub ahead of print. PMID: 40658651.

Tags: Cedars Sinai DoM, Endocrinology, Publications

Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): consensus on obesity and cardiometabolic comorbidities in inflammatory bowel disease using systematic reviews and the RAND/UCLA appropriateness method

Devi J, Samaan S, Sehgal P, Mohamed M, Vincent M, Coombs S, Doering M, Barnes EL, Johnson AM, Yarur AJ, Deepak P. Modulate Obesity and[...]

Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of Hepatic Encephalopathy in Cirrhosis

Singh V, Wang M, Ebinger J, Velazquez A, Cheng S, Kwan AC, Trivedi HD. Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of[...]

Prenatal Substance Exposure and Birth Weight: Findings From the HEALthy Brain and Child Development Study

Bandoli G, Psaras C, Bakhireva LN, Burris HH, Ciciolla L, Coles CD, DeMauro SB, Osmundson SS, Merhar SL, Smith L, Acheson A, Bogdan R, Croff[...]